Rare diseases
Investigational molecules
Locations
7495 New Horizon Way, 21703-8388, United States
Cartesian Therapeutics Inc. focuses its clinical research on generalized myasthenia gravis, a chronic autoimmune neuromuscular disorder marked by muscle weakness and fluctuating functional impairment.
Its clinical activity is centered on patient populations with symptomatic disease burden and functional limitations relevant to daily living.
Cartesian Therapeutics Inc. runs clinical trials in conditions such as Myasthenia gravis, Immune-mediated myasthenia gravis, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
ItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
